Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
about
Recent progress in pancreatic cancerIntegrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastomaKRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysisPancreatic cancer from bench to bedside: molecular pathways and treatment optionsGenetics and biology of pancreatic ductal adenocarcinomaDevelopmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular OriginMolecular detection of pancreatic neoplasia: Current status and future promisePrevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future DirectionsCyst Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and PathologyPerspectives in the treatment of pancreatic adenocarcinomaCytology Specimen Management, Triage and Standardized Reporting of Fine Needle Aspiration Biopsies of the PancreasPancreatic adenocarcinoma pathology: changing "landscape"Multidisciplinary diagnostic and therapeutic approaches to pancreatic cystic lesionsThe role of surgeons in building a personalized medicine programPancreatic cystic neoplasms: Review of current knowledge, diagnostic challenges, and management optionsGenetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencingGenetically engineered mouse models of pancreatic adenocarcinomaEndoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancerHuman correlates of provocative questions in pancreatic pathologyIntraductal Papillary Mucinous Neoplasm of PancreasCRAC: an integrated approach to the analysis of RNA-seq readsA Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the PancreasOncogenic potential of yin yang 1 mediated through control of imprinted genesEvaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancersUse of targeted exome sequencing in genetic diagnosis of Chinese familial hypercholesterolemiaA high throughput screening assay system for the identification of small molecule inhibitors of gspThe molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancersDetection of circulating tumor DNA in early- and late-stage human malignanciesMetabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenineInsights into the Pathogenesis of Pancreatic Cystic Neoplasms.Screening for Pancreatic Cancer.Standardized terminology and nomenclature for pancreatobiliary cytology: The Papanicolaou Society of Cytopathology Guidelines.MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls.A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics.A combination of molecular markers and clinical features improve the classification of pancreatic cysts.Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation.Intraductal papillary mucinous neoplasms of the pancreas: is the puzzle solved?Utility of molecular tests in cytopathologyWhole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.Pathology and molecular genetics of pancreatic neoplasms.
P2860
Q24626346-6423364A-BD4C-408E-A30E-DD82D80226DAQ24630017-2F4D0F3A-FC96-4C22-9150-7BD45529B032Q26741895-0E83AE81-237F-48E3-B788-AB6AA19C5E86Q26747524-8AE52E10-A234-49F4-AF18-C305D51B0307Q26765438-6C7F94E9-4459-41BD-B6B0-131E47EAF01DQ26774942-C84D34E8-46C9-4B9A-B2D2-1BE3A1CEF753Q26777379-45554BF1-BA0C-48AD-AA08-23A122F2A4F5Q26783953-2EAF0B18-19D6-43DD-B644-BA5AFCAFD80DQ26796498-B7A6A94F-16EF-418F-B509-4EBB71A5A2C7Q26797248-BCB6977F-BEA0-4E1B-82CF-F13B13CE14DBQ26799060-3C7D565C-819F-4A24-A8EC-F87F53DEAB80Q26799446-604391F2-3157-471F-8BE3-1A68D6BE13C7Q26829835-FF4F387F-3AA6-4285-A5B6-2264A3EC5AA1Q26849667-71337BE5-56FB-4F97-9CA7-C86BF898E094Q26865466-51FEE4F7-7CD3-4915-97CE-3D343FD23130Q26991615-410F6185-6206-442F-8EDB-E88BFF314418Q27002973-D36E3582-B609-4853-9FDD-8B43510E8F65Q27010209-0B67529E-81FF-40AA-A5FC-4BCEEC5C6806Q27023576-CF9864BF-CF31-4F3D-A537-CEF945BDF32AQ27028114-C9B658A0-1032-4513-9305-A45D9ED594AEQ27499736-90356384-9C14-4E39-91A6-78206C9C00D2Q28082890-D7B51CC6-5222-4A6C-BB6E-F52E0ABEE5C0Q28257555-CADAA4FA-BCEE-4CED-96F1-8A9F206C2903Q28282973-FFF9960C-7982-46B5-845A-5DB652FEB28FQ28537747-9B272BAC-824D-419C-86D2-A3600BC23300Q28541448-BACBDCE6-7396-402A-B6E1-0EEB559E4984Q29395525-24C16227-FF49-44B3-992A-595706B7D30FQ29615778-07A28388-4AFE-40F4-A69E-5A73AD7EFB72Q30010622-E6DBB3E9-B741-4E5C-AF4A-D55D31909F03Q30234478-16F7F3D3-224E-410F-BF7A-E1AF194624E9Q30240971-3645C159-24C8-40D0-A978-26F5FD27E5EAQ30410852-E07777DD-9FEF-4DF7-98DA-6DD25C07A8E2Q30541314-1F5D9268-ED7A-46CA-A7D0-7DD739FD561AQ30669159-BD74D8F6-2F6B-459A-9410-01BE7D0FD1DDQ30724746-BEE70D11-1FC8-4112-A52C-E26348013376Q31162502-2D7C2495-7B38-4EC7-96D6-1BEFD416E76FQ33355493-9E5547A4-6583-4936-86DE-610D1B2B6F2EQ33555932-36E8D656-2C4F-43E2-A2CA-EFA9C937D916Q33570215-26BC63A8-47AC-4EDA-8872-6CAF5C51CD9DQ33581119-76AB9218-F8CA-49DB-9EEC-5B0A29D913B7
P2860
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
@ast
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
@en
type
label
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
@ast
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
@en
prefLabel
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
@ast
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
@en
P2093
P2860
P50
P1476
Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.
@en
P2093
Alison P Klein
Anirban Maitra
Barish H Edil
C Max Schmidt
Christopher L Wolfgang
Hanno Matthaei
James R Eshleman
Laura D Wood
Marcia I Canto
P2860
P304
P356
10.1126/SCITRANSLMED.3002543
P407
P577
2011-07-01T00:00:00Z